ISPR

Ispire Technology Inc. (ISPR) | Rumor.io

Ispire Technology

ISPR

Attention (50-day avg)0%

Attention rank (50-day avg)#2,163

Bullish sentiment (50-day avg)100%

Price to earnings ratio-1.91

Market capitalization76.5M

Earnings per share-0.58

Dividend yield (TTM)—

Revenue (annual)127.5M

Net income (annual)-39.2M

Social

What share of all stock conversation is about ISPR?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% +0	0% +0	0% +0

Mar 17

Ispire Technology Inc. ($ISPR) has broken key resistance levels, with a surge of +32.56% to $2.30, driven by the new FDA framework for flavored ENDS, which unlocks a massive $50B market.
Institutional accumulation is evident, with high-volume trading and a technical target projected to $3.21, as the company's age-verification technology is validated by the regulatory shift.
The new FDA guidance is a major catalyst for Ispire, positioning its technology for significant market share expansion and revaluing assets fundamentally, with a clear regulatory path driving significant asset value reassessment.

Generated by AI

Sentiment

Of the messages about ISPR that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	100%	92.73% +2.45
Bearish	—	—	0%	7.27% -2.45

Mar 17

$ISPR surges to $2.30 +32.56% on significant bullish options flow, catalyzed by the FDA's new flavored ENDS guidance which unlocks a potential $50B market and substantial asset value re-rating.
New FDA guidance unlocks a massive $50B market for flavored ENDS, positioning Ispire's tech for significant market share expansion and driving substantial asset value recognition.
Breakout confirmed as $ISPR smashes $1.91 resistance on a +25.94% surge to $2.19, powered by 550K+ volume and an FDA catalyst unlocking a $50B market, targeting $2.92 next.

Generated by AI

Topics

Of the messages about ISPR that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	100%	75%	83.03%
Earnings	—	0%	25%	2.17%
Analysts	—	0%	0%	0%
Controversies	—	0%	0%	1.44%
Macro	—	0%	0%	4.78%
Technical Analysis	—	0%	0%	8.57%

Mar 17

The FDA's new framework for flavored ENDS has unlocked a massive $50B market, validating Ispire's age-verification tech and positioning the company for significant market share expansion.
Ispire's stock has surged to $2.30 +32.56% on this major regulatory catalyst, with institutional accumulation evident and continued momentum expected.
The company's technology is now a key compliance solution, driving significant asset value reassessment and re-rating as the market recognizes the potential for substantial growth.

Generated by AI

Community

Of the messages about ISPR, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	100%	8.33%	1.6%	3.24%
Newcomers	0%	91.67%	98.4%	96.76%

Mar 17

Newcomers to the $ISPR asset are focused on its recent technical breakouts, with multiple posts highlighting the stock's ability to surpass resistance levels and project future targets.
The FDA's new framework for flavored ENDS is seen as a major catalyst for the $ISPR stock, unlocking a massive $50B market and validating the company's age-verification tech.
Institutional accumulation and momentum are evident in the $ISPR stock, with high-volume trading and a clear regulatory shift driving asset value reassessment and potential for continued growth.

Generated by AI

News

Ispire Highlights Revenue Growth, Cost Control in Investor Update

Detailed price information for Ispire Technology Inc (ISPR-Q) from The Globe and Mail including charting and trades.

6d agoThe Globe and Mail

Ispire Technology Inc (ISPR) (Q4 2026) Earnings Call Highlights: Malaysia Licenses Set Stage ...

Ispire Technology Inc (ISPR) posted 33% Q4 revenue growth and a narrower adjusted EBITDA loss as new Malaysian vapor and nicotine pouch licenses position the company for a breakout fiscal 2027.

13d agoYahoo Finance

Ispire (ISPR) Q4 2026 Earnings Call Transcript

Motley Fool Press Release.

13d agoThe Globe and Mail

Ispire Technology Inc. Q4 2026 Earnings Call Summary

Moby summary of Ispire Technology Inc.'s Q4 2026 earnings call

13d agoYahoo Finance

Ispire Technology Q4 Earnings Call Highlights

Ispire Technology (NASDAQ:ISPR) said it is entering fiscal 2027 with higher quarterly revenue, a reduced operating cost base and new manufacturing licenses in Malaysia, while continuing to work through legacy receivables and pursue commercialization opportunities for its nicotine technology platform

13d agoYahoo Finance

Earnings call transcript: Ispire Q4 2026 revenue jumps 33% as turnaround gains pace

13d agoInvesting.com

Also Discussed

Investors talking about ISPR also mention

#	Name	Attention
1	Babcock & Wilcox Enterprises IncBW	0%0
2	British American Tobacco plc ADRBTI	0.01%+0.01
3	Roma Green Finance LimitedROMA	0%0
4	Baird Medical Investment Holdings Ltd.BDMD	0%new
5	MKDWELL Tech Inc.MKDW	0%+0
6	Edesa Biotech, Inc.EDSA	0%new
7	LanzaTech Global Inc. Common StockLNZA	0%new
8	Distribution Solutions Group, Inc.DSGR	0%0
9	Apogee Therapeutics, Inc. - Common StockAPGE	0%0
10	Bitcoin Depot Inc.BTM	0%0

Ispire Technology Inc.

Consumer Defensive
Tobacco

Ispire Technology Inc. is a technology company focused on the research, design, commercialization, marketing, and distribution of branded e-cigarettes and cannabis vaping products. Its portfolio includes nicotine vaporization products and cannabis vaping hardware sold under the Ispire and Aspire brands, serving regulated markets across multiple regions. The company positions itself around precision nicotine technologies and compliance-oriented vaporization infrastructure, with operations centered on product development, manufacturing, and global distribution. Ispire Technology Inc. also works across the controlled-delivery segment of the vaping industry, supplying products and technologies used by adult consumers and regulated partners. Headquartered in Los Angeles, California, Ispire Technology Inc. plays a role in the broader nicotine and cannabis vaporization market through branded consumer products and hardware platforms designed for regulated commercial use.

Website

Location

19700 Magellan Drive

Los Angeles, CA, 90502

United States

Social

What share of all stock conversation is about ISPR?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% +0	0% +0	0% +0

Mar 17

Ispire Technology Inc. ($ISPR) has broken key resistance levels, with a surge of +32.56% to $2.30, driven by the new FDA framework for flavored ENDS, which unlocks a massive $50B market.
Institutional accumulation is evident, with high-volume trading and a technical target projected to $3.21, as the company's age-verification technology is validated by the regulatory shift.
The new FDA guidance is a major catalyst for Ispire, positioning its technology for significant market share expansion and revaluing assets fundamentally, with a clear regulatory path driving significant asset value reassessment.

Generated by AI

Sentiment

Of the messages about ISPR that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	100%	92.73% +2.45
Bearish	—	—	0%	7.27% -2.45

Mar 17

$ISPR surges to $2.30 +32.56% on significant bullish options flow, catalyzed by the FDA's new flavored ENDS guidance which unlocks a potential $50B market and substantial asset value re-rating.
New FDA guidance unlocks a massive $50B market for flavored ENDS, positioning Ispire's tech for significant market share expansion and driving substantial asset value recognition.
Breakout confirmed as $ISPR smashes $1.91 resistance on a +25.94% surge to $2.19, powered by 550K+ volume and an FDA catalyst unlocking a $50B market, targeting $2.92 next.

Generated by AI

Topics

Of the messages about ISPR that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	100%	75%	83.03%
Earnings	—	0%	25%	2.17%
Analysts	—	0%	0%	0%
Controversies	—	0%	0%	1.44%
Macro	—	0%	0%	4.78%
Technical Analysis	—	0%	0%	8.57%

Mar 17

The FDA's new framework for flavored ENDS has unlocked a massive $50B market, validating Ispire's age-verification tech and positioning the company for significant market share expansion.
Ispire's stock has surged to $2.30 +32.56% on this major regulatory catalyst, with institutional accumulation evident and continued momentum expected.
The company's technology is now a key compliance solution, driving significant asset value reassessment and re-rating as the market recognizes the potential for substantial growth.

Generated by AI

Community

Of the messages about ISPR, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	100%	8.33%	1.6%	3.24%
Newcomers	0%	91.67%	98.4%	96.76%

Mar 17

Newcomers to the $ISPR asset are focused on its recent technical breakouts, with multiple posts highlighting the stock's ability to surpass resistance levels and project future targets.
The FDA's new framework for flavored ENDS is seen as a major catalyst for the $ISPR stock, unlocking a massive $50B market and validating the company's age-verification tech.
Institutional accumulation and momentum are evident in the $ISPR stock, with high-volume trading and a clear regulatory shift driving asset value reassessment and potential for continued growth.

Generated by AI

Ispire Technology

Social

Mar 17

Mar 17

Mar 17

Mar 17

Ispire Highlights Revenue Growth, Cost Control in Investor Update

Ispire Technology Inc (ISPR) (Q4 2026) Earnings Call Highlights: Malaysia Licenses Set Stage ...

Ispire (ISPR) Q4 2026 Earnings Call Transcript

Ispire Technology Inc. Q4 2026 Earnings Call Summary

Ispire Technology Q4 Earnings Call Highlights

Earnings call transcript: Ispire Q4 2026 revenue jumps 33% as turnaround gains pace

Also Discussed

Ispire Technology Inc.

Company Information

Location

Ispire Highlights Revenue Growth, Cost Control in Investor Update

Ispire Technology Inc (ISPR) (Q4 2026) Earnings Call Highlights: Malaysia Licenses Set Stage ...

Ispire (ISPR) Q4 2026 Earnings Call Transcript

Ispire Technology Inc. Q4 2026 Earnings Call Summary

Ispire Technology Q4 Earnings Call Highlights

Earnings call transcript: Ispire Q4 2026 revenue jumps 33% as turnaround gains pace

Also Discussed

Social

Mar 17

Mar 17

Mar 17

Mar 17